Literature DB >> 30227404

How to Define Acute Liver Failure Patients with Pre-Existing Liver Disease without Signs of Cirrhosis.

Aline Gottlieb1, Maren Kottmann2, Paul Manka2, Sotiria Bedreli2, Johannes Hadem1,2, Lars Bechmann1, Jan-Peter Sowa1,2, Guido Gerken2, Ali Canbay3.   

Abstract

BACKGROUND: The definition of acute liver failure (ALF) usually implies no previous liver injury. Though, some patients admitted to liver transplantation centers with the diagnosis of ALF are obese or have diabetes. Elevated liver enzymes were not recorded previously, and no signs of cirrhosis or prior decompensation of the liver function were ever present. Still, these patients differ from the "typical" ALF-patient. GOALS: In this study, we aimed to confirm acute-on-chronic-liver failure (AOCLF) in patients diagnosed with ALF and to identify possible differences between ALF and AOCLF. STUDY: Patients were retrospectively recruited from all patients admitted to the University Hospital Essen with diagnosis of ALF between 2008 and 2015. Data of 163 patients were evaluated, resulting in a reclassification of 32 patients as AOCLF (remaining ALF: 131). Demographic and clinical data as well as serum parameters, including cell death markers, were correlated with clinical outcome.
RESULTS: Patients with AOCLF were significantly older, had a higher body mass index (BMI), and were more often male. The cause for liver failure in these patients differed significantly from patients who had an actual ALF. Significant differences were also found for serum liver enzymes. Outcome of patients did not differ between AOCLF and ALF. Though, lower BMI and MELD and higher AST and GLDH were predictors for a beneficial outcome.
CONCLUSION: AOCLF is still commonly misdiagnosed as ALF. While clinical outcome does not significantly differ between ALF and AOCLF, risk factors for adverse outcome may significantly differ between these entities.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Acute-on-chronic; Clinical management; Outcome

Mesh:

Substances:

Year:  2018        PMID: 30227404     DOI: 10.1159/000492869

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  4 in total

1.  Development and Validation of a Model Consisting of Comorbidity Burden to Calculate Risk of Death Within 6 Months for Patients With Suspected Drug-Induced Liver Injury.

Authors:  Marwan Ghabril; Jiezhun Gu; Lindsay Yoder; Laura Corbito; Amit Ringel; Christian D Beyer; Raj Vuppalanchi; Huiman Barnhart; Paul H Hayashi; Naga Chalasani
Journal:  Gastroenterology       Date:  2019-07-11       Impact factor: 22.682

2.  Novel Prognostic Models for Predicting the 180-day Outcome for Patients with Hepatitis-B Virus-related Acute-on-chronic Liver Failure.

Authors:  Ran Xue; Jun Yang; Jing Wu; Zhongying Wang; Qinghua Meng
Journal:  J Clin Transl Hepatol       Date:  2021-05-17

3.  Different entities of liver failure need clear definitions.

Authors:  Josef Christian Pospiech; Peter Lemmer; Ali Canbay
Journal:  Hepatol Forum       Date:  2021-01-08

Review 4.  Liver failure-future challenges and remaining questions.

Authors:  Peter Lemmer; Josef Christian Pospiech; Ali Canbay
Journal:  Ann Transl Med       Date:  2021-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.